Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Operating Expenses | 2,387 | 1,212 | 396 | 224 | 0 |
| Operating Income | -2,387 | -1,212 | -396 | -224 | N/A |
| Other Income | 4 | 2 | 0 | 0 | 0 |
| Pre-tax Income | -2,383 | -1,210 | -396 | -224 | 0 |
| Net Income Continuous | -2,383 | -1,210 | -396 | -224 | N/A |
| Net Income | $-2,383 | $-1,210 | $-396 | $-224 | $N/A |
| EPS Basic Total Ops | -0.53 | -0.40 | -0.13 | -0.07 | N/A |
| EPS Basic Continuous Ops | -0.52 | -0.40 | -0.13 | -0.07 | N/A |
| EPS Diluted Total Ops | -0.53 | -0.40 | -0.13 | -0.07 | N/A |
| EPS Diluted Continuous Ops | -0.52 | -0.40 | -0.13 | -0.07 | N/A |
| EBITDA(a) | $-2,385 | $-1,212 | $-396 | $-224 | $N/A |